120 related articles for article (PubMed ID: 16696316)
1. Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin.
Wang X; Luo C; Liu J; Zhang C; Wang Y; Zhu Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):651-4. PubMed ID: 16696316
[TBL] [Abstract][Full Text] [Related]
2. [The expression of connective tissue growth factor in renal cortex of 5/6 nephrectomized rats and its modulation by fluvastatin].
Song GW; Li C; Zheng YC; Kong J; Sun B
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1428-32. PubMed ID: 14521748
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway.
Zhang L; Liu J; Liu Y; Xu Y; Zhao X; Qian J; Sun B; Xing C
Clin Exp Nephrol; 2015 Jun; 19(3):336-42. PubMed ID: 24942605
[TBL] [Abstract][Full Text] [Related]
4. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
5. Significance and expression of serum and glucocorticoid-inducible kinase in kidney of mice with diabetic nephropathy.
Wang Q; Zhang X; Wang Y; Deng A; Zhu Z; Feng Y
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):170-3. PubMed ID: 16116964
[TBL] [Abstract][Full Text] [Related]
6. [Effects of fluvastatin on the activation of p38 mitogen-activated protein kinase in glomerular mesangial cells under high concentration of glucose].
Wang LH; Wu GL; Zhang LX; Huang XD; Li S
Yao Xue Xue Bao; 2009 Feb; 44(2):121-5. PubMed ID: 19408679
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation.
Song Y; Li C; Cai L
Exp Mol Pathol; 2004 Feb; 76(1):66-75. PubMed ID: 14738871
[TBL] [Abstract][Full Text] [Related]
8. [The effect of valsartan and fluvastatin on the connective tissue growth factor expression in experimental diabetic cardiomyopathy].
Wang YJ; Fu GS; Chen FM; Wang H
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):660-5. PubMed ID: 19954059
[TBL] [Abstract][Full Text] [Related]
9. [Effects of fluvastatin on the expression of Janus kinase 2/signal transducers and activators of transcription (JAK/STAT) in glomerular mesangial cells under high concentration of glucose].
Shi YH; Zhao S; Ren YZ; Liu QJ; Duan HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jul; 20(7):422-5. PubMed ID: 18611343
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditions.
Shi YH; Zhao S; Wang C; Li Y; Duan HJ
Acta Pharmacol Sin; 2007 Dec; 28(12):1938-46. PubMed ID: 18031608
[TBL] [Abstract][Full Text] [Related]
11. [Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells].
Xie Y; Wang Q; Liu J; Xie J; Xue K; Tang Q
Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(15):1996-2000. PubMed ID: 20931854
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
Gao P; Wu X; Shui H; Jia R
J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes.
Salis O; Okuyucu A; Bedir A; Gör U; Kulcu C; Yenen E; Kılıç N
Tumour Biol; 2016 Mar; 37(3):3017-24. PubMed ID: 26419593
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy.
Miao XJ; Bi TT; Tang JM; Lv R; Gui DK; Yang XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10482-10488. PubMed ID: 31841202
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin attenuates diabetes-induced cardiac sympathetic neuropathy in association with a decrease in oxidative stress.
Matsuki A; Nozawa T; Igarashi N; Sobajima M; Ohori T; Suzuki T; Fujii N; Igawa A; Inoue H
Circ J; 2010 Mar; 74(3):468-75. PubMed ID: 20103973
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature.
Shida T; Nozawa T; Sobajima M; Ihori H; Matsuki A; Inoue H
Heart Vessels; 2014 Jul; 29(4):532-41. PubMed ID: 23979266
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
[TBL] [Abstract][Full Text] [Related]
19. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
20. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
